• Please log in or register to access this feature.

Bioseparations and Downstream Processing

Process development and cGMP manufacturing of a recombinant ricin vaccine: An effective and stable recombinant ricin a-chain vaccine—RVEc™†

  1. Michael M. Meagher1,
  2. Javier G. Seravalli1,
  3. S. Todd Swanson1,
  4. Roger G. Ladd1,
  5. Yogender P. Khasa1,
  6. Mehmet Inan1,
  7. Jay C. Harner1,
  8. Scott K. Johnson1,
  9. Kevin Van Cott1,
  10. Changhong Lindsey2,
  11. Robert Wannemacher3,
  12. Leonard A. Smith4,*

Article first published online: 31 MAY 2011

DOI: 10.1002/btpr.631

Issue

Biotechnology Progress

Biotechnology Progress

Volume 27, Issue 4, pages 1036–1047, July/August 2011

Additional Information

How to Cite

Meagher, M. M., Seravalli, J. G., Swanson, S. T., Ladd, R. G., Khasa, Y. P., Inan, M., Harner, J. C., Johnson, S. K., Van Cott, K., Lindsey, C., Wannemacher, R. and Smith, L. A. (2011), Process development and cGMP manufacturing of a recombinant ricin vaccine: An effective and stable recombinant ricin a-chain vaccine—RVEc™. Biotechnol Progress, 27: 1036–1047. doi: 10.1002/btpr.631

Author Information

  1. 1

    University of Nebraska-Lincoln Biological Process Development Facility, College of Engineering, University of Nebraska-Lincoln, Lincoln, NE 68588-0668

  2. 2

    Office of Regulated Studies, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702

  3. 3

    Dept. of Integrated Toxicology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011

  4. 4

    Senior Research Scientist (ST), Office of Chief Scientist, United States Army Medical Research Institute of Infectious Diseases, and Medical Countermeasures Technology, United States Army Medical Research and Material Command, Fort Detrick, MD 21702-5011

*Senior Research Scientist (ST), Medical Countermeasures Technology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011

  1. †

    This article is a U.S. Government work, and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 3 AUG 2011
  2. Article first published online: 31 MAY 2011
  3. Accepted manuscript online: 20 APR 2011 01:43PM EST
  4. Manuscript Revised: 25 MAR 2011
  5. Manuscript Received: 20 DEC 2010

Funded by

  • Joint Science and Technology Office for Chemical-Biological Defense (DTRA)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1750K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Get PDF (1750K)